HopeStage
Back to all studies
CompletedNCT02520388

HLD200 for ADHD in Everyday Settings for Children Ages 6 to 12

About this titleRead the official source — NCT02520388
Medication studyAges 6–12United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 6 years to 12 years.

Listed locations
Newport Beach and 20 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateAugust 2015
Recruitment status
Completed
Enrollment listed in the registry
163
Sponsor
Ironshore Pharmaceuticals and Development, Inc
Sponsor type
Other organization
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 6 Years to 12 Years
Official registry ID
NCT02520388
Official title
Show the full official title

Ph 3 Multicenter DBRCT Parallel Group Study to Evaluate Safety & Efficacy of Evening-dosed HLD200, a Novel Delayed & Extended Release Formulation (DELEXIS) of MPH HCl, on Post-waking, Early Morning Function in Children Aged 6-12 With ADHD

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Newport Beach · Bradenton · Gainesville

16 more locations
  • Jacksonville
  • Maitland
  • North Miami
  • Orange City
  • Orlando
  • South Miami
  • Winter Park
  • Owensboro
  • Durham
  • Oklahoma City
  • Memphis
  • Houston
  • Lubbock
  • San Antonio
  • Clinton
  • Seattle

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Ironshore Pharmaceuticals and Development, Inc.

Did this study involve medication?

Yes. The study involved medication, including HLD200 methylphenidate hydrochloride (MPH) Capsules and Placebo.

Who was this study for?

Listed age limits: 6 years to 12 years.

Want to explore more studies?

Explore studies